Sa1747 SAFETY OF IMMUNOSUPPRESSION IN A PROSPECTIVE COHORT OF INFLAMMATORY BOWEL DISEASE PATIENTS WITH A HISTORY OF CANCER: UPDATES FROM THE SAPPHIRE ...

1178 PROMISING EFFICACY OF SMALL MOLECULES AND BIOLOGICALS FOR MICROSCOPIC COLITIS: RESULTS FROM A LARGE REAL-LIFE MULTICENTER COHORT

27 DEVELOPMENT AND VALIDATION OF AN INTEGRATED RISK SCORE FOR PREDICTING FUTURE RISK OF CROHN'S DISEASE UP TO 7 YEARS BEFORE DIAGNOSIS IN HEALTHY ...

9 MECHANISTIC IMPLICATIONS OF THE MEDITERRANEAN DIET IN PATIENTS WITH NEWLY DIAGNOSED CROHN'S DISEASE- MULTI-OMIC ANALYSIS OF A PROSPECTIVE COHORT

Sa1822 IMPACT OF OBESITY ON POUCH COMPLICATIONS IN A POPULATION-BASED COHORT OF PATIENTS WITH ULCERATIVE COLITIS

Sa1746 MULTIPLE BIOSIMILAR INFLIXIMAB SWITCHING IS NOT ASSOCIATED WITH ADVERSE OUTCOMES IN INFLAMMATORY BOWEL DISEASE: A REAL-WORLD EFFECTIVENESS ANALYSES ...

Design and setting of the studyThe TEMPO (Trajectoires EpidéMiologiques en POpulation) study was set up in 2009 among French adults aged 22 to 35 years who ...

INTRODUCTION:  Achalasia is a postulated risk factor of esophageal cancer (EC); however, EC-associated risk in achalasia is ...

A small advantage for early initiation of biologics was demonstrated in CD, but this was not the case in UC.

Helicobacter pylori infection is associated with a decreased risk of esophageal adenocarcinoma, and the declining prevalence of such infection might ...